Literature DB >> 27000511

Dose and Volume of the Irradiated Main Bronchi and Related Side Effects in the Treatment of Central Lung Tumors With Stereotactic Radiotherapy.

Marloes Duijm1, W Schillemans1, Joachim G Aerts2, B Heijmen1, Joost J Nuyttens3.   

Abstract

High radiation dose to the main bronchi can result in stenosis, occlusion or fistula formation, and death. Only 8 articles have reported side effects to the main bronchi from stereotactic body radiation therapy (SBRT), mostly with only one symptomatic complication per article. Therefore, we calculated the dose to the bronchial structures, such as trachea; mainstem bronchi; intermediate bronchus; upper-, middle-, and lower-lobe bronchus; and the segmental bronchi in 134 patients with central tumors and calculated the normal tissue complication probability (NTCP) for each of these structures, with toxicity determination based upon computed tomography imaging. No side effects were found in the trachea, and only stenosis occurred in the main bronchus and bronchus intermedius. Higher grades of side effects, such as occlusion and atelectasis, were only seen in the upper-, middle-, and lower bronchi and the segmental bronchi. When 0.5cc of a segmental bronchi was irradiated to 50Gy in 5 fractions, it was about 50% likely to be occluded radiographically. For grade 1 radiographically evident side effects, the 50% risk level for a 5-fraction Dmax was 55Gy for mid-bronchi and 65Gy for mainstem bronchi. To assure the relationship between clinical toxicity and side effects to the bronchi, further investigation is needed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 27000511     DOI: 10.1016/j.semradonc.2015.11.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  8 in total

1.  Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.

Authors:  Amode R Tembhekar; Cari L Wright; Megan E Daly
Journal:  Clin Lung Cancer       Date:  2016-12-22       Impact factor: 4.785

Review 2.  Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?

Authors:  Feng-Ming Spring Kong; Vitali Moiseenko; Jing Zhao; Michael T Milano; Ling Li; Andreas Rimner; Shiva Das; X Allen Li; Moyed Miften; ZhongXing Liao; Mary Martel; Soren M Bentzen; Andrew Jackson; Jimm Grimm; Lawrence B Marks; Ellen Yorke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-26       Impact factor: 8.013

Review 3.  Doses, fractionations, constraints for stereotactic radiotherapy.

Authors:  Simona Borghesi; Cynthia Aristei; Francesco Marampon
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22

Review 4.  Radiobiological Optimization in Lung Stereotactic Body Radiation Therapy: Are We Ready to Apply Radiobiological Models?

Authors:  Marco D'Andrea; Silvia Strolin; Sara Ungania; Alessandra Cacciatore; Vicente Bruzzaniti; Raffaella Marconi; Marcello Benassi; Lidia Strigari
Journal:  Front Oncol       Date:  2018-01-08       Impact factor: 6.244

5.  Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.

Authors:  Mao-Bin Meng; Huan-Huan Wang; Nicholas G Zaorsky; Bing-Shen Sun; Lei Zhu; Yong-Chun Song; Feng-Tong Li; Yang Dong; Jing-Sheng Wang; Hua-Ming Chen; Xu-Yao Yu; Zhi-Yong Yuan
Journal:  Cancer Sci       Date:  2019-09-09       Impact factor: 6.716

6.  Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy.

Authors:  Zhigong Wei; Xingchen Peng; Yan Wang; Lianlian Yang; Ling He; Zheran Liu; Jingjing Wang; Xiaoli Mu; Ruidan Li; Jianghong Xiao
Journal:  Radiat Oncol       Date:  2021-08-30       Impact factor: 3.481

7.  Segmental resection of the main left bronchus due to adenoid cystic carcinoma.

Authors:  Aleksandra Chrząstek; Przemysław Bławat; Łukasz Żołna; Janusz Kowalewski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-03-24

Review 8.  GSTP1 as a novel target in radiation induced lung injury.

Authors:  Xiao Lei; Lehui Du; Wei Yu; Yao Wang; Na Ma; Baolin Qu
Journal:  J Transl Med       Date:  2021-07-08       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.